YONGIN, South Korea, June 4, 2024 /PRNewswire/ -- GC Biopharma announced that it will attend 2024 Spring Symposium of the Korean American Society in Biotech and Pharmaceuticals (KASBP) on June 7-8th ...

Staying informed on the latest trends in mergers and acquisitions (M&A) is crucial for investors looking to capitalize on ...

"Similarly, we have seen distinct signs of progress in our intellectual property litigation, with the quick resolution of co-ownership and co-inventorship claims made by Acuitas Therapeutics and ...

New Jersey federal judge said Acuitas had failed to show case or controversy | Acuitas had sought declaratory judgment that ...

Judge dismisses case since Acuitas doesn’t make, sell vaccine Clash over tiny balls of fat in Pfizer, BioNTech’s Comirnaty A New Jersey federal judge dismissed Acuitas Therapeutics’ lawsuit seeking a ...

This partnership will allow Aldevron to expand its capabilities in mRNA LNP encapsulation by incorporating Acuitas’ proprietary LNP encapsulation platform, increasing Aldevron’s services and ...

This partnership will allow Aldevron to expand its capabilities in mRNA LNP encapsulation by incorporating Acuitas’ proprietary LNP encapsulation platform, increasing Aldevron’s services and ...

This partnership will allow Aldevron to expand its capabilities in mRNA LNP encapsulation by incorporating Acuitas’ proprietary LNP encapsulation platform, increasing Aldevron’s services and ...

This partnership will allow Aldevron to expand its capabilities in mRNA LNP encapsulation by incorporating Acuitas’ proprietary LNP encapsulation platform, increasing Aldevron’s services and ...

He tweets @anees_avis Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas’ lawsuit demanding credit for inventions related to COVID-19 vaccines, according to a ...